BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 18061886)

  • 1. Status of terpenes as skin penetration enhancers.
    Aqil M; Ahad A; Sultana Y; Ali A
    Drug Discov Today; 2007 Dec; 12(23-24):1061-7. PubMed ID: 18061886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
    Drug Dev Ind Pharm; 2011 May; 37(5):583-96. PubMed ID: 21469947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical penetration enhancers: a patent review.
    Ahad A; Aqil M; Kohli K; Chaudhary H; Sultana Y; Mujeeb M; Talegaonkar S
    Expert Opin Ther Pat; 2009 Jul; 19(7):969-88. PubMed ID: 19552513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Terpenes as Penetration Enhancers for Transdermal Drug Delivery.
    Chen J; Jiang QD; Chai YP; Zhang H; Peng P; Yang XX
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27973428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration enhancers.
    Williams AC; Barry BW
    Adv Drug Deliv Rev; 2004 Mar; 56(5):603-18. PubMed ID: 15019749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development and evaluation of terpene penetration enhancers].
    Hua N; Liu W; Guo RC
    Zhongguo Zhong Yao Za Zhi; 2008 Dec; 33(24):2875-82. PubMed ID: 19294840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complexes formation between drugs and penetration enhancers in transdermal delivery.
    Drakulić BJ; Juranić IO; Erić S; Zloh M
    Int J Pharm; 2008 Nov; 363(1-2):40-9. PubMed ID: 18675333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of penetration enhancers on drug delivery through skin: a QSAR study.
    Ghafourian T; Zandasrar P; Hamishekar H; Nokhodchi A
    J Control Release; 2004 Sep; 99(1):113-25. PubMed ID: 15342185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
    Wen Z; Fang L; He Z
    Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin.
    Kang L; Yap CW; Lim PF; Chen YZ; Ho PC; Chan YW; Wong GP; Chan SY
    J Control Release; 2007 Jul; 120(3):211-9. PubMed ID: 17582639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous penetration enhancers: an overview.
    Thong HY; Zhai H; Maibach HI
    Skin Pharmacol Physiol; 2007; 20(6):272-82. PubMed ID: 17717423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous permeation enhancement by terpenes: mechanistic view.
    Sapra B; Jain S; Tiwary AK
    AAPS J; 2008; 10(1):120-32. PubMed ID: 18446512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin absorption enhancers.
    Williams AC; Barry BW
    Crit Rev Ther Drug Carrier Syst; 1992; 9(3-4):305-53. PubMed ID: 1458546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transdermal delivery of loratadine from the EVA matrix.
    Cho CW; Choi JS; Kim SJ; Shin SC
    Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.
    Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY
    Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.
    Chen Y; Wang M; Fang L
    Drug Deliv; 2013; 20(5):199-209. PubMed ID: 23763451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.